Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Behrens

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
HIV Medicine|September 25, 2014
Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort studyC Hoffmann, M Hentrich, D Gillor, et al.
AIDS (London, England)|December 12, 2001
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profileM van der Valk, J J Kastelein, R L Murphy, et al.
HIV Medicine|March 2, 2018
Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0L Ryom, C Boesecke, M Bracchi, et al.
Nature Communications|November 21, 2019
Author Correction: A human immune dysregulation syndrome characterized by severe hyperinflammation with a homozygous nonsense Roquin-1 mutationS J Tavernier, V Athanasopoulos, P Verloo, et al.
Nature Communications|October 23, 2019
A human immune dysregulation syndrome characterized by severe hyperinflammation with a homozygous nonsense Roquin-1 mutationS J Tavernier, V Athanasopoulos, P Verloo, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
HIV Medicine|September 25, 2014
Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort studyC Hoffmann, M Hentrich, D Gillor, et al.
AIDS (London, England)|December 12, 2001
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profileM van der Valk, J J Kastelein, R L Murphy, et al.
HIV Medicine|March 2, 2018
Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0L Ryom, C Boesecke, M Bracchi, et al.
Nature Communications|November 21, 2019
Author Correction: A human immune dysregulation syndrome characterized by severe hyperinflammation with a homozygous nonsense Roquin-1 mutationS J Tavernier, V Athanasopoulos, P Verloo, et al.
Nature Communications|October 23, 2019
A human immune dysregulation syndrome characterized by severe hyperinflammation with a homozygous nonsense Roquin-1 mutationS J Tavernier, V Athanasopoulos, P Verloo, et al.
Pageof 6